Re:Cognition Health wins Bridges Positive Impact Award

We’re delighted to announce the 2019 winner of the Bridges Positive Impact Award – our new category at the Growing Business Awards, which is intended to recognise growth businesses that are having a positive impact on people or the planet.

Like last year, we received a host of remarkable entries for this year’s prize. But there was a clear winner: Re:Cognition Health, a leader in the diagnosis, treatment and care management of individuals experiencing cognitive impairment.

There are currently around 850,000 people with dementia in the UK, and this is projected to rise to 1.6 million by 2040. Re:Cognition Health is committed to shaping a future without dementia through research and education. With five clinics in the UK and one in the US, it provides access to best-in-market medications for Alzheimer’s disease (the most common cause of dementia). It also supports research into next-generation treatments via international clinical trials.

Philip Newborough, co-CEO of Bridges, said: “We launched the Bridges Positive Impact award to recognise growth businesses that are helping to create a better future for people or the planet. Re:Cognition Health’s goal is to solve the ‘unacceptable problem’ of dementia. Someone develops dementia every three seconds, and one in three people born today will die with it. Re:Cognition is helping to tackle this crisis by diagnosing, treating and developing new medicines for those affected. This year’s shortlist featured an impressive array of high-growth, high-impact businesses, but Re:Cognition really stood out. It’s the fastest growing business of its kind in the world, it’s improving the lives of millions of people and it has ambitious plans for further growth, both in the UK and the US.”